Crucial role of phospholipase Cε in induction of local skin inflammatory reactions in the elicitation stage of allergic contact hypersensitivity

Journal of Immunology

Volumn 184, Issue 2, 2010, Pages 993-1002

  Hu, Lizhi ^a   Edamatsu, Hironori ^a   Takenaka, Nobuyuki ^a   Ikuta, Shuzo ^a   Kataoka, Tohru ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; PHOSPHOLIPASE C; PHOSPHOLIPASE C EPSILON; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 1 FLUORO 2,4 DINITROBENZENE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CELL TRANSFER; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EAR; FIBROBLAST; KERATINOCYTE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN INFLAMMATION; SWELLING; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CONTACT DERMATITIS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DERMATITIS, CONTACT; DINITROFLUOROBENZENE; FIBROBLASTS; INFLAMMATION; KERATINOCYTES; MICE; MICE, KNOCKOUT; PHOSPHOINOSITIDE PHOSPHOLIPASE C;

EID: 76249133493     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901816     Document Type: Article

References (43)

1. Robinson, L., and I. Thorn. 2005. Contact hypersensitivity (allergic contact dermatitis). In Toxicology and Ecotoxicology in Chemical Safety Assessment. L. Robinson, and I. Thorn, eds. Wiley-Blackwell, Hoboken, NJ, pp. 24-25.
2. + lymphocyte homing and initiation of late-phase inflammation in contact sensitivity. J. Exp. Med. 199: 1223-1234.
3. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27: 485-517.
4. Grassegger, A., and R. Höpfl. 2004. Significance of the cytokine interferon γ in clinical dermatology. Clin. Exp. Dermatol. 29: 584-588.
5. Rhee, S. G. 2001. Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70: 281-312.
6. Katan, M. 2005. New insights into the families of PLC enzymes: looking back and going forward. Biochem. J. 391: e7-e9.
7. Kelley, G. G., S. E. Reks, J. M. Ondrako, and A. V. Smrcka. 2001. Phospholipase C(ε): a novel Ras effector. EMBO J. 20: 743-754.
8. Lopez, I., E. C. Mak, J. Ding, H. E. Hamm, and J. W. Lomasney. 2001. A novel bifunctional phospholipase c that is regulated by Galpha 12 and stimulates the Ras/mitogen-activated protein kinase pathway. J. Biol. Chem. 276: 2758-2765.
9. Song, C., C. D. Hu, M. Masago, K. Kariyai, Y. Yamawaki-Kataoka, M. Shibatohge, D. Wu, T. Satoh, and T. Kataoka. 2001. Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras. J. Biol. Chem. 276: 2752-2757.
10. Bunney, T. D., and M. Katan. 2006. Phospholipase C ε: linking second messengers and small GTPases. Trends Cell Biol. 16: 640-648.
11. Bai, Y., H. Edamatsu, S. Maeda, H. Saito, N. Suzuki, T. Satoh, and T. Kataoka. 2004. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development. Cancer Res. 64: 8808-8810.
12. Ikuta, S., H. Edamatsu, M. Li, L. Hu, and T. Kataoka. 2008. Crucial role of phospholipase C ε in skin inflammation induced by tumor-promoting phorbol ester. Cancer Res. 68: 64-72.
13. Li, M., H. Edamatsu, R. Kitazawa, S. Kitazawa, and T. Kataoka. 2009. Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis. Carcinogenesis 30: 1424-1432.
14. Tadano, M., H. Edamatsu, S. Minamisawa, U. Yokoyama, Y. Ishikawa, N. Suzuki, H. Saito, D. Wu, M. Masago-Toda, Y. Yamawaki-Kataoka, et al. 2005. Congenital semilunar valvulogenesis defect in mice deficient in phospholipase Cε. Mol. Cell. Biol. 25: 2191-2199.
15. Wu, D., M. Tadano, H. Edamatsu, M. Masago-Toda, Y. Yamawaki-Kataoka, T. Terashima, A. Mizoguchi, Y. Minami, T. Satoh, and T. Kataoka. 2003. Neuronal lineage-specific induction of phospholipase Cepsilon expression in the developing mouse brain. Eur. J. Neurosci. 17: 1571-1580.
16. Czyzyk, J., J. L. Brogdon, A. Badou, O. Henegariu, P. Preston Hurlburt, R. Flavell, and K. Bottomly. 2003. Activation of CD4 T cells by Raf-independent effectors of Ras. Proc. Natl. Acad. Sci. U.S.A. 100: 6003-6008.
17. H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651.
18. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450.
19. Tuckermann, J. P., A. Kleiman, R. Moriggl, R. Spanbroek, A. Neumann, A. Illing, B. E. Clausen, B. Stride, I. Förster, A. J. Habenicht, et al. 2007. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J. Clin. Invest. 117: 1381-1390.
20. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
21. Sehra, S., H. A. Bruns, A. N. Ahyi, E. T. Nguyen, N. W. Schmidt, E. G. Michels, G. U. von Bülow, and M. H. Kaplan. 2008. IL-4 is a critical determinant in the generation of allergic inflammation initiated by a constitutively active Stat6. J. Immunol. 180: 3551-3559.
22. Wang, B., C. Esche, A. Mamelak, I. Freed, H. Watanabe, and D. N. Sauder. 2003. Cytokine knockouts in contact hypersensitivity research. Cytokine Growth Factor Rev. 14: 381-389.
23. Cassatella, M. A. 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16: 21-26.
24. Liang, S. C., X. Y. Tan, D. P. Luxenberg, R. Karim, K. Dunussi-Joannopoulos, M. Collins, and L. A. Fouser. 2006. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203: 2271-2279.
25. van Beelen, A. J., M. B. Teunissen, M. L. Kapsenberg, and E. C. de Jong. 2007. Interleukin-17 in inflammatory skin disorders. Curr. Opin. Allergy Clin. Immunol. 7: 374-381.
26. Ogura, H., M. Murakami, Y. Okuyama, M. Tsuruoka, C. Kitabayashi, M. Kanamoto, M. Nishihara, Y. Iwakura, and T. Hirano. 2008. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29: 628-636.
27. Dinarello, C. A. 2002. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20(5, Suppl 27)S1-S13.
28. Rossi, D., and A. Zlotnik. 2000. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18: 217-242.
29. Laing, K. J., and C. J. Secombes. 2004. Chemokines. Dev. Comp. Immunol. 28: 443-460.
30. Schutyser, E., S. Struyf, and J. Van Damme. 2003. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14: 409-426.
31. 2+ entry. Immunity 22: 451-465.
32. Suh, P. G., J. I. Park, L. Manzoli, L. Cocco, J. C. Peak, M. Katan, K. Fukami, T. Kataoka, S. Yun, and S. H. Ryu. 2008. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 41: 415-434.
33. Ichinohe, M., Y. Nakamura, K. Sai, M. Nakahara, H. Yamaguchi, and K. Fukami. 2007. Lack of phospholipase C-δ1 induces skin inflammation. Biochem. Biophys. Res. Commun. 356: 912-918.
34. Qian, Y., C. Liu, J. Hartupee, C. Z. Altuntas, M. F. Gulen, D. Jane-Wit, J. Xiao, Y. Lu, N. Giltiay, J. Liu, et al. 2007. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8: 247-256.
35. Pène, J., S. Chevalier, L. Preisser, E. Vénéreau, M. H. Guilleux, S. Ghannam, J. P. Molès, Y. Danger, E. Ravon, S. Lesaux, et al. 2008. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol. 180: 7423-7430.
36. Kirkham, B. W., M. N. Lassere, J. P. Edmonds, K. M. Juhasz, P. A. Bird, C. S. Lee, R. Shnier, and I. J. Portek. 2006. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a twoyear prospective study (the DAMAGE study cohort). Arthritis Rheum. 54: 1122-1131.
37. Krueger, G. G., R. G. Langley, C. Leonardi, N. Yeilding, C. Guzzo, Y. Wang, L. T. Dooley, and M. Lebwohl; CNTO 1275 Psoriasis Study Group. 2007. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N. Engl. J. Med. 356: 580-592.
38. Lowes, M. A., T. Kikuchi, J. Fuentes-Duculan, I. Cardinale, L. C. Zaba, A. S. Haider, E. P. Bowman, and J. G. Krueger. 2008. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J. Invest. Dermatol. 128: 1207-1211.
39. Yen, D., J. Cheung, H. Scheerens, F. Poulet, T. McClanahan, B. McKenzie, M. A. Kleinschek, A. Owyang, J. Mattson, W. Blumenschein, et al. 2006. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116: 1310-1316.
40. Molet, S., Q. Hamid, F. Davoine, E. Nutku, R. Taha, N. Pagé, R. Olivenstein, J. Elias, and J. Chakir. 2001. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108: 430-438.
41. Moore, R. J., D. M. Owens, G. Stamp, C. Arnott, F. Burke, N. East, H. Holdsworth, L. Turner, B. Rollins, M. Pasparakis, et al. 1999. Mice deficient in tumor necrosis factor-a are resistant to skin carcinogenesis. Nat. Med. 5: 828-831.
42. Coussens, L. M., and Z. Werb. 2002. Inflammation and cancer. Nature 420: 860-867.
43. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related in- flammation. Nature 454: 436-444.